ORCL
63
-4
STT
64
2
URBN
48
-6
PEP
39
-9
WMB
68
2
GIS
22
-4
CMG
66
-4
PLD
45
-5
COP
57
-2
PEG
62
4
TGNA
50
-6
AMAT
33
-13
XEL
67
2
INTU
58
-3
WM
74
-5
PFE
14
-7
ABT
59
2
DHR
32
-6
UNH
57
-2
NAVI
52
-2
ORCL
63
-4
STT
64
2
URBN
48
-6
PEP
39
-9
WMB
68
2
GIS
22
-4
CMG
66
-4
PLD
45
-5
COP
57
-2
PEG
62
4
TGNA
50
-6
AMAT
33
-13
XEL
67
2
INTU
58
-3
WM
74
-5
PFE
14
-7
ABT
59
2
DHR
32
-6
UNH
57
-2
NAVI
52
-2
Financhill
Back

IGC Pharma Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
24

IGC
IGC Pharma

Last Price:
0.34
Seasonality Move:
-9.08%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
24
IGC Pharma (IGC) is a Sell

Is IGC Pharma a Buy, Sell or Hold?

  • The current IGC Pharma [IGC] share price is $0.34. The Score for IGC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • IGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IGC Stock Price Chart

What is IGC Pharma's stock price today?

  • The IGC Pharma share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

IGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 32.09 Sell
Chaikin Money Flow: -223947 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.36 - 0.4) Sell
Bollinger Bands (100): (0.36 - 0.44) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

IGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.37 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.37 Sell
200-day SMA: 0.41 Sell
8-day EMA: 0.37 Sell
20-day EMA: 0.38 Sell
50-day EMA: 0.38 Sell
200-day EMA: 0.4 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

IGC Pharma Earnings Growth & IGC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

IGC Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):